| Net Cash Provided by (Used in) Operating Activities |
-214K |
USD |
-203% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
150K |
USD |
+47.1% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
5B |
shares |
+900% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
2B |
shares |
+1143% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
47.3K |
USD |
-12.8% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
5.24M |
USD |
+0.66% |
Q2 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q2 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
15K |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
5.25M |
USD |
+146% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
810K |
USD |
-95.9% |
Q3 2025 |
Q1 2026 |
| Operating Leases, Future Minimum Payments, Due in Two Years |
1.5K |
USD |
|
Q3 2025 |
Q1 2026 |
| Depreciation, Depletion and Amortization |
116K |
USD |
-16.6% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
3.12M |
USD |
+59.9% |
Q1 2025 |
Q3 2025 |
| Operating Leases, Future Minimum Payments Due |
14.2K |
USD |
|
Q3 2025 |
Q1 2026 |
| Interest Expense |
694K |
USD |
+2.78% |
Q3 2025 |
Q1 2026 |